Uncover impactful insights in cancer genomics.
)
Reveal more cancer biology.
Go beyond next-generation sequencing (NGS). With the ability to read any length of DNA or RNA — short to ultra-long — nanopore technology captures more genomic variation to reveal novel cancer biology.
Generate ultra-rich multiomic cancer data and take investigations further with direct RNA sequencing to rapidly identify fusion genes and RNA isoforms. Leverage direct DNA or RNA methylation sequencing to unlock the epigenome.
Accelerate your cancer research.
Be the first to discover novel cancer biology. With a comprehensive view of structural variants (SVs) and methylation sequencing, nanopore technology transforms cancer genomic data into actionable insights for all stages of discovery.
Read how researchers have used nanopore sequencing to comprehensively characterise colorectal cancer samples to detect novel gene fusions and reveal previously hidden SVs.
)
)
Answer cancer research questions you didn’t even know you had.
Tumour genomics, cancer biomarkers, liquid biopsy research; who says you can’t have it all? With genomics, epigenetics, and transcriptomics, our multiomics toolkit provides the content and clarity you need — even at single-cell resolution.
Our end-to-end workflows provide a seamless option to answer cancer research questions you didn't even know you had.
Detect somatic variation between tumour-normal paired research samples to enable a deeper understanding of cancer epigenetics. Single nucleotide variants (SNVs), SVs, copy number variants (CNVs), short tandem repeats (STRs), and epigenetic modifications are all captured in a single dataset.
Every cancer insight you can imagine, and then some.
A cancer-free future starts with a transformative view of the methylome, genome, and transcriptome — all from a single platform. With our unique multiomics toolkit, you’ll never see cancer the same way again.
Through the facility to generate nanopore reads of any length — from 20 bp up to ultra-long reads in excess of 4 Mb — combined with integrated base modification detection and real-time results, nanopore sequencing delivers a streamlined and rapid solution for the complete characterisation of cancer samples.
)
Comprehensive insight into cancer genomes.
Hear how scientists are using nanopore technology to sequence different cancer research samples to generate ultra-rich data for answers with impact.
Catch up with our latest on-demand webinars.
CoRAL accurately resolves extrachromosomal DNA structures with long-read sequencing
Application and use of long-read sequencing in personalised cancer medicine
An (epi-)genomics analysis of drug resistance in multiple myeloma
One platform — multiple techniques.
Kits to get you started.
)
Genomic and transcriptomic sequencing using up to 24 independent, high-capacity flow cells — for in-depth characterisation of large numbers of clinical research samples.
)
Offering two independent PromethION Flow Cells for low-cost access to high-output sequencing — ideal for smaller sample number whole-genome and transcriptome projects.
)
From gene expression analysis to high-throughput targeted mutation detection, run multiple experiments on-demand using five independent MinION Flow Cells.
)
Portable nanopore sequencing device — suitable for targeted panels, exome sequencing, and gene expression studies.
)
Adapting MinION and GridION for smaller, rapid tests and analyses, on single-use flow cells; ideal for low-plex targeted sequencing and library quality control.
Subscribe
Get in touch
If you have any questions about our products or services, chat directly with a member of our sales team.
To book a call with one of our sales team, please click below.